Library Subscription: Guest
Journal of Environmental Pathology, Toxicology and Oncology

Published 4 issues per year

ISSN Print: 0731-8898

ISSN Online: 2162-6537

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.4 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.8 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.5 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00049 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.59 SJR: 0.429 SNIP: 0.507 CiteScore™:: 3.9 H-Index: 49

Indexed in

Colorectal Cancer in Crohn's Disease—Review of a 56-Year Experience in Karolinska Institute University Hospital

Volume 27, Issue 4, 2008, pp. 257-266
DOI: 10.1615/JEnvironPatholToxicolOncol.v27.i4.20
Get accessGet access

ABSTRACT

We previously reported that the frequency of colorectal carcinomas (CRC) in Crohn's disease (CD) had increased at this hospital between 1951 and May 1996. The aim was to compare the frequency of CRC in CD between June 1996 and September 2007 to that found between 1951 and May 1996. For that purpose colectomy specimens with an IBD-CRC diagnosis filed during the last 11 years were reviewed. It was found that 29 patients with IBD developed a CRC at this hospital: 21 had CD (or 1.91 cases/year) and the remaining eight, ulcerative colitis (or 0.72 cases/year). At this hospital, the number of cases of CRC in Crohn's colitis increased from 0.28/year between 1951 and the end of 1989, to 1.69 patients/year between 1990 and May 1996, and to 1.91 patients/year between June 1996 and September 2007 (present report). The marginal increase number of patients with CRC in Crohn's colitis/year during the last 11 years at this hospital might be only apparent, considering that the incidence of Crohn's disease in the county has dramatically increased, and that the localization of Crohn's disease has changed in later years, with a predilection for the colon and rectum.

CITED BY
  1. Ruffolo Cesare, Scarpa Marco, Polese Lino, D’Amico Francesco E., Boetto Riccardo, Pozza Anna, D’Incà Renata, Checchin Davide, Sturniolo Giacomo Carlo, Bassi Nicolò, Angriman Imerio, Clinical Presentation and Diagnosis of Intestinal Adenocarcinoma in Crohn’s Disease: Analysis of Clinical Predictors and of the Life-Time Risk, Journal of Gastrointestinal Surgery, 14, 11, 2010. Crossref

  2. González-Sarrías Antonio, Larrosa Mar, Tomás-Barberán Francisco Abraham, Dolara Piero, Espín Juan Carlos, NF-κB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts, British Journal of Nutrition, 104, 4, 2010. Crossref

  3. Ismail Tariq, Akhtar Saeed, Riaz Muhammad, Pomegranate Peel and Fruit Extracts, in Exploring the Nutrition and Health Benefits of Functional Foods, 2017. Crossref

  4. Ismail Tariq, Akhtar Saeed, Riaz Muhammad, Pomegranate Peel and Fruit Extracts, in Complementary and Alternative Medicine, 2019. Crossref

  5. Scaioli Eleonora, Belluzzi Andrea, Ricciardiello Luigi, Del Rio Daniele, Rotondo Enrica, Mena Pedro, Derlindati Eleonora, Danesi Francesca, Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial, Trials, 20, 1, 2019. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain